Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MegaNatural-BP claims supported

This article was originally published in The Tan Sheet

Executive Summary

Constellation Wines U.S./PolyPhenolics supports certain claims for its MegaNatural-BP dietary supplement, but should "clearly and conspicuously" communicate the supplement could be used as a part of a lifestyle management program by those with prehypertension and metabolic syndrome, the National Advertising Division states in an Oct. 14 decision. The advertiser submitted two clinical trials, which NAD says provide a reasonable basis for claims such as: "In the second study on participants with prehypertension, their systolic blood pressure dropped 8 mm and diastolic dropped 5 mm when taking 300 mg once per day for 2 months." The Council for Better Business Bureaus group recommends discontinuing the claim, "Provide relief with half the cost, half the dose and half the time," but says the advertiser can discuss the differences between MegaNatural-BP and antigen-converting enzyme inhibitors

You may also be interested in...



Could Eledon’s Anti-CD40L Change Transplant Medicine?

Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation. 

Turning That Frown Upside Down: Treating Depression With Facial Botox Injections

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel